LC
Laura Chico Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
63
Avg Return
Past Year
Past Year
20%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
71.8%
Neutral
21.1%
Negative
7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Consumer Discretionary
Residential Construction
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $12 |
118%
upside
| 4 | +24% |
0
%
| 3 Mar ‘26 21 hours ago |
|
|
|
Neutral
Maintained
| $18 |
11%
downside
| 1 | – |
–
| 25 Feb ‘26 6 days ago |
|
|
|
Neutral
Downgraded
| $1 |
113%
upside
| 4 | +2% |
0
%
| 24 Feb ‘26 7 days ago |
|
|
|
Outperform
Reiterated
| $19 |
205%
upside
| 3 | +20% |
0
%
| 23 Feb ‘26 8 days ago |
|
|
|
Underperform
Maintained
| $130 |
59%
downside
| 5 | -77% |
0
%
| 20 Feb ‘26 11 days ago |
|
|
|
Neutral
Reiterated
| $25 |
13%
upside
| 2 | – |
–
| 17 Feb ‘26 14 days ago |
|
|
|
Outperform
Maintained
| $151 |
15%
upside
| 2 | -2% |
0
%
| 12 Feb ‘26 19 days ago |
|
|
|
Outperform
Maintained
| $55 |
1%
downside
| 7 | +15% |
0
%
| 11 Feb ‘26 20 days ago |
|
|
|
Neutral
Maintained
| $187 |
2%
upside
| 4 | – |
–
| 10 Feb ‘26 21 days ago |
|
|
|
Outperform
Maintained
| $36 |
7%
upside
| 3 | +40% |
0
%
| 12 Jan ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $30 |
50%
upside
| 3 | +15% |
0
%
| 11 Dec ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $33 |
16%
downside
| 2 | – |
–
| 11 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $47 |
60%
upside
| 1 | -7.8% |
0
%
| 10 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $30 |
12%
upside
| 3 | +21% |
0
%
| 13 Nov ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $36 |
19%
downside
| 2 | +97% |
0
%
| 7 Nov ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $32 |
11%
upside
| 2 | +48% |
0
%
| 7 Nov ‘25 3 months ago |
|
|
|
Neutral
Downgraded
| $13 | – | 2 | +79% |
0
%
| 15 Oct ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $8 |
25%
upside
| 2 | +56% |
0
%
| 30 Sep ‘25 5 months ago |
|
|
|
Neutral
Downgraded
| $48 | – | 3 | +55% |
0
%
| 9 Sep ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $18 |
29%
upside
| 3 | +21% |
0
%
| 14 Aug ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $14 |
135%
upside
| 2 | +66% |
0
%
| 13 Aug ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $43 |
2%
downside
| 1 | +28% |
0
%
| 12 Aug ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $32 |
13%
upside
| 3 | +16% |
0
%
| 7 Aug ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $18 |
107%
upside
| 1 | -7.2% |
0
%
| 30 Jun ‘25 8 months ago |
|
|
|
Neutral
Reiterated
| $130 |
20%
upside
| 1 | – |
–
| 18 Jun ‘25 8 months ago |
|